Basilea Pharmaceutica Ltd (PK5)
Market Closed
19 Jun, 20:00
XDUS 
€
54. 70
-0.1
-0.1825%
€
- Market Cap
7.96 P/E Ratio
20% Div Yield
0 Volume
2.9 Eps
€ 54.8
Previous Close Want to track PK5 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Basilea Pharmaceutica Ltd (PK5) Statistics
Valuation metrics
Market Cap -
Enterprise value -70.58M
Trailing P/E (ttm) 17.66
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -0.3
Enterprise Value/EBITDA -1.38
Overview
Shares outstanding 12.29M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1
Average volume (90 days) -
Price summary
52-Week low 47.9
52-Week high 65.2
Beta -
50-Day moving average 58.49
200-Day moving average 55.45
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Jun 2013
Ex-Dividend Date 11 Apr 2013
Last split factor 1,039:1,029
Last split Date 13 Mar 2007
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.83%
Operating margin 0.21%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.31%
Income Statement
Revenue (ttm) 232.38M
Revenue per share (ttm) 18.98
Quarterly revenue growth (yoy) -
Gross profit (ttm) 193.06M
EBITDA 51.05M
Net income to common (ttm) 40.24M
Diluted EPS (ttm) 3.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 27.1M
Total cash per share (mrq) -
Total debt (mrq) 89.22M
Total Debt/Equity (mrq) 0.7
Current ratio (mrq) 5.11%
Book value per share (mrq) -
Cash Flow
Cash flow statement 49.04M
Levered free cash flow (LFCF) 40.24M
